← back to search

Eunhee Kim

Seoul National University · KR
Area of research
Information Systems · Epidemiology
Research interest
Research interests include Education and Learning Interventions, Acute Ischemic Stroke Management, Lymphoma Diagnosis and Treatment, and Cerebrospinal fluid and hydrocephalus.
h-index
33
citations
4,177
works
151
NIH funding
—
primary concept
Medicine
email
ehkim@unist.ac.kr

Recent publications

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma
Blood 2023cited by 97position: middledoi
Five-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL)
Blood 2021cited by 23position: middledoi
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Blood 2019cited by 328position: middledoi
Three-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma
Blood 2019cited by 22position: middledoi
Two-Year Follow-up of Keynote-087 Study: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma
Blood 2018cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Pauline Brice · Hôpital Saint-Louis5 papers (2018–2023)Craig H. Moskowitz · City of Hope5 papers (2018–2023)John Radford · University of Manchester5 papers (2018–2023)Margaret A. Shipp · Harvard University5 papers (2018–2023)Hun Ju Lee · The University of Texas MD Anderson Cancer Center5 papers (2018–2023)Vincent Ribrag · Institut Gustave Roussy5 papers (2018–2023)Nathalie A. Johnson · Jewish General Hospital5 papers (2018–2023)Bastian von Tresckow · Heidelberg University5 papers (2018–2023)Akihiro Tomita · Fujita Health University5 papers (2018–2023)Philippe Armand · Harvard University5 papers (2018–2023)Daniel Molin · Uppsala University5 papers (2018–2023)Theodoros P. Vassilakopoulos · National and Kapodistrian University of Athens5 papers (2018–2023)Pier Luigi Zinzani · Marche Polytechnic University5 papers (2018–2023)Jianxin Lin · Merck & Co., Inc., Rahway, NJ, USA (United States)4 papers (2019–2023)Alex F. Herrera · City Of Hope National Medical Center3 papers (2019–2023)Patricia Marinello · Merck & Co., Inc., Rahway, NJ, USA (United States)3 papers (2019–2023)Akash Nahar · Daiichi Sankyo (United States)2 papers (2018–2019)Samhita Chakraborty · National Institute of Pharmaceutical Education and Research2 papers (2021–2023)Arun Balakumaran · Allogene Therapeutics (United States)2 papers (2018–2019)Robert Chen · Xuzhou Medical College1 papers (2019–2019)